Figure 2.

Overview of frequency of clinical and developmental assessments in patients with NF1. [Source: Bergqvist et al, 2020 (1); Miller et al., 2019 (35)]. ADD, attention-deficit disorder; MRI, magnetic resonance imaging; NF1, neurofibromatosis type 1. * At the time of diagnosis in an infant (1 month to 1 year). **Indicates to be performed in infants and children (1 year to adolescent). ***Advise for more frequent visits as indicated in children (5 years to adolescent). ^#At least once in this time period in children (5 years to adolescent).